M&A Deal Summary

Ixo Private Equity Acquires Optimum

On October 1, 2015, private equity firm Ixo Private Equity acquired furniture company Optimum from Azulis Capital

Acquisition Highlights
  • This is Ixo Private Equity’s 2nd transaction in the Furniture sector.
  • This is Ixo Private Equity’s 13th transaction in France.

M&A Deal Summary
Date 2015-10-01
Target Optimum
Sector Furniture
Buyer(s) Ixo Private Equity
Sellers(s) Azulis Capital
Deal Type Secondary Buyout

Target

Optimum

Le Passage, France
Optimum manufactures and markets of wood products. Optimum was founded in 1981 and is based in Le Passage, France.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ixo Private Equity

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2002
PE ASSETS 800M EUR
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Ixo Private Equity is a private investment firm focused on acquiring and investing in companies at all stages, including venture, growth, and buyout. The Firm's buyout group does not have any sector preferences and looks to invest €1 to €30 million. Ixo's geographic preference is for opportunities throughout Western Europe. Ixo Private Equity was formed in 2002 and is based in Toulouse, France.

DEAL STATS #
Overall 15 of 52
Sector (Furniture) 2 of 2
Type (Secondary Buyout) 3 of 4
Country (France) 13 of 48
Year (2015) 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-03-23 Fleuret

Saint-Orens-de-Gameville, France

Fleuret Designs and manufactures tailor-made technological containers for the industrial environment, in particular aeronautics and space. Fleuret was founded in 1987 and is based in Saint-Orens-de-Gameville, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-01 GamaMabs Pharma

Toulouse, France

GamaMabs Pharma is an immuno-oncology biotechnology company, provides the development of optimized antibodies targeting AMHR2 for the treatment of cancer. The company develops low-fucose EMABling® antibodies (license granted by LFB) with increased tumor cell killing properties through a breakthrough activation of immune cells. GamaMabs Pharma was founded in 2013 and is based in Toulouse, France.

Buy -

Seller(S) 1

SELLER

Azulis Capital

Paris, France

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2000
PE ASSETS 1.0B EUR
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Azulis Capital is a private equity investment firm that targets buyout, recapitalization, and growth capital investments in France. Azulis looks to invest in mid-sized businesses with €20 to €120 million in enterprise value. Sectors of interest include consumer products and services, manufacturing, communications, healthcare, and chemicals. Azulis generally seeks to commit between €7 and €30 million per transaction. Azulis Capital was formerly known as Banexi Capital and is based in Paris.

DEAL STATS #
Overall 34 of 49
Sector (Furniture) 2 of 2
Type (Secondary Buyout) 16 of 28
Country (France) 34 of 49
Year (2015) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-23 Numalliance

Saint-Michel-sur-Meurthe, France

Numalliance is a manufacturer of CNC machine tools specializing in bending and cold forming of metal wires, tubes, and flats. Numalliance is based in Saint-Michel-sur-Meurthe, France.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-22 Marcel & Fils

Venelles, France

Marcel & Fils is a retail chain specializing in organic products in the south of France. The Company offers a large range, mostly of food products (fruit and vegetables, fresh produce, bread, groceries, patisseries and savouries, gluten-free products, etc.) while also providing complimentary organic products such as cosmetics, nutritional supplements, home care items, and baby products, etc. Marcel & Fils was formed in 2008 and is based in Venelles, France.

Buy -
Mergr

Product

Company

Legal